Tresivac PFS Vaccine

Tresivac PFS Vaccine is a prescription medicine. This combination of three vaccines is used to prevent Measles, Mumps and Rubella. It stimulates the immune system to act against microorganisms to prevent such infections. These infections can occur in people of any age group.

Tresivac PFS Vaccine is to be administered by a healthcare professional. It may cause redness, pain, and swelling at the site of injection. However, this is temporary and usually resolves on its own. Do not skip any doses and follow your doctor's instructions carefully to get maximum benefit.

Tresivac PFS Vaccine is generally safe to use with minimal side effects. However, it may cause a few side effects such as rash and fever. Please consult your doctor if these do not subside or bother you. Your doctor will suggest ways to cope up with the side effects.

Before taking it, inform your doctor if you are suffering from any liver or kidney problems. Pregnant and breastfeeding mothers should consult their doctor before taking it.

• Prevention of Measles
• Prevention of Rubella
• Prevention of Mumps

Prevention of Measles
Measles is a viral infection that starts in the respiratory system. It causes skin rashes that spread all over the body. It spreads from person to person through direct contact as well as through air. Tresivac PFS Vaccine is used in preventing measles. It works by causing your body to produce its own protection (antibodies) against the disease. It is advisable to consult your doctor for complete information regarding vaccination schedules.

Prevention of Rubella
Rubella is a viral infection that causes red rash on the body. It is transmitted by airborne droplets when infected people sneeze or cough. It occurs most often in children and young adults. Rubella infection in pregnant women can result in miscarriage, stillbirth or serious birth defects. Tresivac PFS Vaccine helps protect against this infection.

Prevention of Mumps
Mumps is a viral disease that spreads from person to person through close contact. The most noticeable symptom is swelling in the face. This is due to swelling of the salivary gland located inside on both sides of the face. It also causes severe pain especially while eating or talking. Tresivac PFS Vaccine is given for the prevention of mumps. You can consult your doctor to guide you better on vaccination schedules.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Tresivac

• Rash
• Injection site soreness
• Fever

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Tresivac PFS Vaccine is a combination of three vaccines, which prevents measles, mumps, and rubella. It helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.

• Tresivac PFS Vaccine helps prevent measles, mumps & rubella.
• It is given by injection under the skin or into a muscle by your doctor.
• It can also be given to older children, adolescents and adults who were either not vaccinated in childhood, or didn't have two doses of the vaccine.
• Inform your doctor if you or your child has an infection with a high temperature, as vaccination may need to be delayed until recovery.
• Do not take Tresivac PFS Vaccine if you are pregnant. Avoid getting pregnant for one month after having this vaccine.
• It may cause fever. Inform your doctor if it does not go away or if the fever gets too high (more than 102 degree fahrenheit).
• This vaccine may cause mild measles or mumps-type symptoms. However, it is not infectious.

Priorix [Measles, Mumps and Rubella Vaccine (Live) IP]. Nabha (Punjab), India: GlaxoSmithKline Asia Private Limited; 1999 [revised 26 Sep. 2018]. [Accessed 15 Jul. 2019] (online) Available from:

Priorix [rubella vaccine + measles vaccine + mumps vaccine]. Uxbridge, Middlesex: GlaxoSmithKline UK; 1997 [revised 16 Jan. 2019]. [Accessed 15 Jul. 2019] (online) Available from: